Provided by Tiger Trade Technology Pte. Ltd.

Ionis Pharmaceuticals

72.69
+0.35000.48%
Volume:1.12M
Turnover:81.58M
Market Cap:12.01B
PE:-30.54
High:73.29
Open:72.35
Low:71.92
Close:72.34
52wk High:86.74
52wk Low:23.95
Shares:165.19M
Float Shares:164.00M
Volume Ratio:0.57
T/O Rate:0.68%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.3800
EPS(LYR):-2.3812
ROE:-70.80%
ROA:-7.31%
PB:24.55
PE(LYR):-30.53

Loading ...

Ionis Pharmaceuticals announces Phase 3 CORE, CORE2 met primary endpoint

TIPRANKS
·
Nov 10, 2025

Ionis Pharmaceuticals Unveils Positive Olezarsen Study Results for sHTG Treatment

Reuters
·
Nov 09, 2025

Analysts Offer Insights on Healthcare Companies: Ionis Pharmaceuticals (IONS) and Immunocore Holdings (IMCR)

TIPRANKS
·
Nov 09, 2025

Olezarsen Achieves Up to 72% Triglyceride Reduction in Phase 3 sHTG Trials

Reuters
·
Nov 08, 2025

Ionis Pharmaceuticals EVP Brian Birchler Reports Sale of Common Shares

Reuters
·
Nov 08, 2025

William Blair Reaffirms Their Buy Rating on Ionis Pharmaceuticals (IONS)

TIPRANKS
·
Nov 05, 2025

Ionis Pharmaceuticals Is Maintained at Overweight by Piper Sandler

Dow Jones
·
Nov 05, 2025

U.S. RESEARCH ROUNDUP-Affiliated Managers Group, Argenx, Cardinal Health

Reuters
·
Nov 04, 2025

Ionis Pharmaceuticals Director Joseph H. Wender Reports Sale of Common Shares

Reuters
·
Nov 04, 2025

Ionis Pharmaceuticals Amends 8-K to Add Advisory Agreement with Richard Geary

Reuters
·
Nov 04, 2025

Earnings Update: Here's Why Analysts Just Lifted Their Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Price Target To US$81.91

Simply Wall St.
·
Nov 01, 2025

Ionis Pharmaceuticals Faces Investor Risks Amid Market Volatility and Milestone Uncertainties

TIPRANKS
·
Oct 31, 2025

Ionis Pharmaceuticals, Inc. : H.c. Wainwright Raises Target Price to $100 From $95

THOMSON REUTERS
·
Oct 30, 2025

Ionis Pharmaceuticals Inc : Bernstein Raises Target Price to $65 From $50

THOMSON REUTERS
·
Oct 30, 2025

Ionis Pharmaceuticals Is Maintained at Buy by Needham

Dow Jones
·
Oct 30, 2025

Ionis Pharmaceuticals: Strong Q3 Performance and Promising Pipeline Drive Buy Rating

TIPRANKS
·
Oct 30, 2025

Ionis Pharmaceuticals Inc : Barclays Raises Target Price to $95 From $80

THOMSON REUTERS
·
Oct 30, 2025

Ionis Pharmaceuticals Inc : TD Cowen Raises Target Price to $99 From $59

THOMSON REUTERS
·
Oct 30, 2025

Ionis Pharmaceuticals Inc : Leerink Partners Raises Target Price to $72.00 From $68.00

THOMSON REUTERS
·
Oct 30, 2025

Ionis Pharmaceuticals Shines in Q3 2025 Earnings Call

TIPRANKS
·
Oct 30, 2025